Zilver Vena
Payments companies reported to CMS as associated with Zilver Vena. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zilver Vena, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zilver Vena
These are the largest totals companies reported as associated with Zilver Vena. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Gagne | Darien, CT | Vascular Surgery | $84,727.04 |
| Elsie Ross | San Diego, CA | Vascular Surgery | $17,980.00 |
| Dejah Judelson | Worcester, MA | Vascular Surgery | $14,321.01 |
| Jeffrey Apple | Austin, TX | Surgery | $14,229.94 |
| Omar Al-Nouri | La Jolla, CA | Vascular Surgery | $12,400.00 |
| Kush Desai | Chicago, IL | Vascular & Interventional Radiology | $11,940.91 |
| Mitchell Silver | Columbus, OH | Interventional Cardiology | $9,675.00 |
| Gloria Salazar | Chapel Hill, NC | Vascular & Interventional Radiology | $8,520.00 |
| Mark Meissner | Seattle, WA | Vascular Surgery | $8,232.93 |
| Sreekumar Madassery | Chicago, IL | Vascular & Interventional Radiology | $7,671.88 |
Prescribed Zilver Vena?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.